Sequenom Inc. (SQNM) Shares Fall 5% on U.S. District Court Ruling
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Join SI Premium – FREE
Shares of Sequenom Inc. (Nasdaq: SQNM) are trading down 5% on news a U.S. district court has denied the company's request for a preliminary injunction against Ariosa Diagnostics.
Sequenom is trying to prevent Ariosa from selling prenatal tests that can detect abnormalities in chromosomes. Back in February, SQNM filed a patent infringement suit against Ariosa.
Currently, Sequenom has it's own test it sells, MaterniT21 - which is made to detect certain chromosomal abnormalities, including Down Syndrome.
Sequenom is trying to prevent Ariosa from selling prenatal tests that can detect abnormalities in chromosomes. Back in February, SQNM filed a patent infringement suit against Ariosa.
Currently, Sequenom has it's own test it sells, MaterniT21 - which is made to detect certain chromosomal abnormalities, including Down Syndrome.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Nu Skin EVP of global sales takes medical leave
- Home Depot expands executive roles, grants $500K in restricted stock
Create E-mail Alert Related Categories
Corporate News, Litigation, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
